HIV Cure Research

About ViiV Healthcare

ViiV Healthcare is a unique, HIV-focused pharmaceutical company established as a joint venture by GSK, Pfizer, and Shionogi. It has built a leading portfolio of antiretroviral therapies, including long-acting injectable regimens, and maintains a robust pipeline aimed at treatment, prevention, and cure. The company operates with a deep commitment to the HIV community, leveraging partnerships and implementation science to address unmet needs and health disparities globally.

Therapeutic Areas